3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Solid Tumors
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Lymphoma
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Cancers
1
Interventions
Temozolomide
30
Radiotherapy
21
Etoposide
9
Carboplatin
9
Bevacizumab
9
Cyclophosphamide
8
Vincristine
7
Radiation
7
Filgrastim
7
Cisplatin
7
Magnetic Resonance Spectroscopy
6
Irinotecan
5
Ifosfamide
5
Granulocyte Colony-Stimulating Factor
5
etoposide phosphate
4
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Lomustine
4
Everolimus
4
selpercatinib
3
larotrectinib
3
Thalidomide
3
Paclitaxel
3
Nuclear Medicine Department, Hospital
3
Methotrexate
3
Erlotinib Hydrochloride
3
Chemotherapy, Adjuvant
3
Celecoxib
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Central Nervous System Neoplasms
×
ridaforolimus
×
Clear all
No trials found.